Human Anti-Aβ42 Recombinant Antibody (clone HT7) (CAT#: HPAB-A1231-YJ)

This product is a Human antibody that recognizes Aβ42.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
DB

Figure 1 Dot Blot analysis of Aβ42 monomers, oligomers, protofibrils, and fibrils (10 μM each, 10 μL each) probed with B4 and scFv HT7.

Figure 1 Dot Blot analysis of Aβ42 monomers, oligomers, protofibrils, and fibrils (10 μM each, 10 μL each) probed with B4 and scFv HT7.

Zhang, Y., Huai, Y., Zhang, X., Song, C., Cai, J., & Zhang, Y. (2019). The mode of action of an anti-oligomeric amyloid β-protein antibody affects its protective efficacy. Neurotoxicity Research, 35, 304-317.

WB

Figure 2 Western Blot analysis of various Aβ42 species, ranging from Aβ42 monomers to fibrils, probed with scFv HT7, and the mixture of the four Aβ42 species was probed with B4 antibody (positive control).

Figure 2 Western Blot analysis of various Aβ42 species, ranging from Aβ42 monomers to fibrils, probed with scFv HT7, and the mixture of the four Aβ42 species was probed with B4 antibody (positive control).

Zhang, Y., Huai, Y., Zhang, X., Song, C., Cai, J., & Zhang, Y. (2019). The mode of action of an anti-oligomeric amyloid β-protein antibody affects its protective efficacy. Neurotoxicity Research, 35, 304-317.

FunS

Figure 3 Effects of scFv HT7 on Aβ42-induced cytotoxicity as estimated by MTT cell viability.

Figure 3 Effects of scFv HT7 on Aβ42-induced cytotoxicity as estimated by MTT cell viability.

Zhang, Y., Huai, Y., Zhang, X., Song, C., Cai, J., & Zhang, Y. (2019). The mode of action of an anti-oligomeric amyloid β-protein antibody affects its protective efficacy. Neurotoxicity Research, 35, 304-317.

Inhib

Figure 4 Neutralization and inhibition of Aβ42-induced cytotoxicity by scFv HT7 were compared by MTT assay.

Figure 4 Neutralization and inhibition of Aβ42-induced cytotoxicity by scFv HT7 were compared by MTT assay.

Zhang, Y., Huai, Y., Zhang, X., Song, C., Cai, J., & Zhang, Y. (2019). The mode of action of an anti-oligomeric amyloid β-protein antibody affects its protective efficacy. Neurotoxicity Research, 35, 304-317.

Neut

Figure 5 SH-SY5Y cell profiles in the presence of Aβ42 oligomers or Aβ42 oligomers plus scFv HT7.

Figure 5 SH-SY5Y cell profiles in the presence of Aβ42 oligomers or Aβ42 oligomers plus scFv HT7.

Zhang, Y., Huai, Y., Zhang, X., Song, C., Cai, J., & Zhang, Y. (2019). The mode of action of an anti-oligomeric amyloid β-protein antibody affects its protective efficacy. Neurotoxicity Research, 35, 304-317.

IHC

Figure 6 Robust somatodendritic tau accumulation was detected in the brains of 3xTg-AD mice at 6, 12, and 18 months of age using the human specific tau antibody HT7.

Figure 6 Robust somatodendritic tau accumulation was detected in the brains of 3xTg-AD mice at 6, 12, and 18 months of age using the human specific tau antibody HT7.

Oddo, S., Caccamo, A., Tseng, B., Cheng, D., Vasilevko, V., Cribbs, D. H., & LaFerla, F. M. (2008). Blocking Aβ42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Aβ and tau pathology. Journal of Neuroscience, 28(47), 12163-12175.


Specifications

  • Host Species
  • Human
  • Type
  • Human IgG
  • Specificity
  • Human Aβ42
  • Species Reactivity
  • Human
  • Clone
  • HT7
  • Applications
  • ELISA, DB, Inhib
  • Related Disease
  • Alzheimer's disease

Product Property

  • Purification
  • Protein A/G Purified
  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • See the COA
  • Buffer
  • PBS
  • Storage
  • Store at 4°C for short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Enzyme-linked Immunosorbent Assay, Dot Blot, Inhibition.

Target

  • Alternative Names
  • Beta-amyloid peptide; beta-APP; Amyloid-beta; Aβ; Abeta; Abeta42; APP; Amyloid

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Aβ42"

Recombinant Antibody

CAT Product Name Application Type
MOB-25 Recombinant Anti-human Aβ42 Antibody WB, FC, FuncS IgG
MHH-25 Recombinant Human Anti-human Aβ42 Antibody FC, WB, FuncS IgG
FAMAB-0160-CN Human Anti-Aβ42 Recombinant Antibody (clone scFv59) WB, ELISA, IF, IHC Human IgG
HPAB-0511-WJ Mouse Anti-Aβ42 Recombinant Antibody (clone 3F5) Inhib, ELISA, Live cell imaging, FuncS Mouse IgG2b
HPAB-2064-FY Human Anti-Aβ42 Recombinant Antibody (clone 8F5) Neut, ELISA, DB, IF Human IgG

Intrabody

CAT Product Name Application Type
IAB-B042(A) Recombinant Anti-human Aβ42 Intrabody [(D-Arg)9] CO-IP, FuncS scFv-(D-Arg)9
IAB-B042(G) Recombinant Anti-human Aβ42 Intrabody [+36 GFP] ELISA, IF, Neut, FuncS scFv-(+36GFP)
IAB-B042(T) Recombinant Anti-human Aβ42 Intrabody [Tat] ELISA, Neut, FuncS scFv-Tat

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-A1231-YJ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare